Century Therapeutics Inc (IPSC)
2.99
-0.14
(-4.47%)
USD |
NASDAQ |
May 17, 16:00
2.99
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Shareholders Equity (Quarterly): 177.88M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 177.88M |
| December 31, 2023 | 184.75M |
| September 30, 2023 | 219.23M |
| June 30, 2023 | 247.57M |
| March 31, 2023 | 277.18M |
| December 31, 2022 | 302.74M |
| September 30, 2022 | 330.20M |
| Date | Value |
|---|---|
| June 30, 2022 | 357.95M |
| March 31, 2022 | 386.66M |
| December 31, 2021 | 396.24M |
| September 30, 2021 | 422.99M |
| June 30, 2021 | 447.60M |
| March 31, 2021 | -91.56M |
| December 31, 2020 | -106.41M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-106.41M
Minimum
Dec 2020
447.60M
Maximum
Jun 2021
253.79M
Average
289.96M
Median
Shareholders Equity (Quarterly) Benchmarks
| Verastem Inc | 46.22M |
| Entero Therapeutics Inc | 3.603M |
| Gritstone Bio Inc | 13.96M |
| Allogene Therapeutics Inc | 461.37M |
| Mirum Pharmaceuticals Inc | 234.60M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 348.51M |
| Total Liabilities (Quarterly) | 170.62M |
| Current Ratio | 12.44 |
| Net Debt Paydown Yield | 0.76% |